MXPA04003969A - Sistema de expresion de acido nucleico regulado. - Google Patents
Sistema de expresion de acido nucleico regulado.Info
- Publication number
- MXPA04003969A MXPA04003969A MXPA04003969A MXPA04003969A MXPA04003969A MX PA04003969 A MXPA04003969 A MX PA04003969A MX PA04003969 A MXPA04003969 A MX PA04003969A MX PA04003969 A MXPA04003969 A MX PA04003969A MX PA04003969 A MXPA04003969 A MX PA04003969A
- Authority
- MX
- Mexico
- Prior art keywords
- nucleic acid
- expression system
- acid expression
- regulated nucleic
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16051—Methods of production or purification of viral material
- C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invencion proporciona construcciones de acido nucleico, sistemas de expresion, y metodos que se relacionan a la regulacion de la expresion genetica. La invencion puede aplicarse para regular la expresion de cualquier secuencia de codificacion de interes, incluyendo aquellas que codifican para los componentes virales necesarios para el empaque de particulas virales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/020,472 US6835568B2 (en) | 2001-10-30 | 2001-10-30 | Regulated nucleic acid expression system |
PCT/US2002/034932 WO2003054210A2 (en) | 2001-10-30 | 2002-10-30 | Regulated nucleic acid expression system |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04003969A true MXPA04003969A (es) | 2004-07-08 |
Family
ID=21798805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04003969A MXPA04003969A (es) | 2001-10-30 | 2002-10-30 | Sistema de expresion de acido nucleico regulado. |
Country Status (15)
Country | Link |
---|---|
US (2) | US6835568B2 (es) |
EP (1) | EP1446488A4 (es) |
JP (1) | JP2005512573A (es) |
KR (1) | KR100984268B1 (es) |
CN (1) | CN100591769C (es) |
AU (1) | AU2002365090B2 (es) |
BR (1) | BR0213964A (es) |
CA (1) | CA2464268C (es) |
CZ (1) | CZ2004546A3 (es) |
IL (2) | IL161495A0 (es) |
MX (1) | MXPA04003969A (es) |
NO (1) | NO20041763L (es) |
NZ (1) | NZ533132A (es) |
RU (1) | RU2004116319A (es) |
WO (1) | WO2003054210A2 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7297536B2 (en) * | 2003-01-23 | 2007-11-20 | Wisconsin Alumni Research Foundation | Inducible protein expression system |
US20090123494A1 (en) * | 2007-07-31 | 2009-05-14 | William Staplin | Momlv-based pseudovirion packaging cell line |
AU2009228183A1 (en) * | 2008-03-28 | 2009-10-01 | Virxsys Corporation | Lentivirus-based immunogenic vectors |
CA2780671A1 (en) * | 2009-11-05 | 2011-05-12 | Proyecto De Biomedicina Cima, S.L. | Regulated expression system |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
RU2749717C2 (ru) * | 2015-11-24 | 2021-06-16 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Способ временной трансфекции для продуцирования ретровируса |
CA3006288A1 (en) * | 2015-11-24 | 2017-06-01 | Glaxosmithkline Intellectual Property Development Limited | Stable cell lines for retroviral production |
AU2018356538B2 (en) * | 2017-10-25 | 2023-09-28 | Nouscom Ag | Eukaryotic cell line |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2140380T5 (es) | 1990-03-21 | 2005-03-16 | Geneart Gmbh | Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas. |
US6174666B1 (en) * | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
US5750396A (en) * | 1995-05-08 | 1998-05-12 | St. Judes Children's Research Hospital | Stable virus packaging cell lines |
US5885806A (en) * | 1995-11-28 | 1999-03-23 | The Johns Hopkins University School Of Medicine | Methods to prepare conditionally replicating viral vectors |
US5888767A (en) * | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
US6133027A (en) * | 1996-08-07 | 2000-10-17 | City Of Hope | Inducible expression system |
GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
HUP0201019A2 (en) | 1999-04-26 | 2002-08-28 | Leuven K U Res & Dev | Synthetic gene for expressing active retroviral protein in eukaryotes |
-
2001
- 2001-10-30 US US10/020,472 patent/US6835568B2/en not_active Expired - Fee Related
-
2002
- 2002-10-30 BR BRPI0213964-2A patent/BR0213964A/pt not_active Application Discontinuation
- 2002-10-30 CA CA2464268A patent/CA2464268C/en not_active Expired - Fee Related
- 2002-10-30 WO PCT/US2002/034932 patent/WO2003054210A2/en not_active Application Discontinuation
- 2002-10-30 EP EP20020802938 patent/EP1446488A4/en not_active Withdrawn
- 2002-10-30 IL IL16149502A patent/IL161495A0/xx unknown
- 2002-10-30 KR KR1020047006464A patent/KR100984268B1/ko not_active IP Right Cessation
- 2002-10-30 MX MXPA04003969A patent/MXPA04003969A/es active IP Right Grant
- 2002-10-30 AU AU2002365090A patent/AU2002365090B2/en not_active Ceased
- 2002-10-30 NZ NZ533132A patent/NZ533132A/en not_active IP Right Cessation
- 2002-10-30 CN CN02821442A patent/CN100591769C/zh not_active Expired - Fee Related
- 2002-10-30 JP JP2003554911A patent/JP2005512573A/ja active Pending
- 2002-10-30 CZ CZ2004546A patent/CZ2004546A3/cs unknown
- 2002-10-30 RU RU2004116319/13A patent/RU2004116319A/ru not_active Application Discontinuation
-
2004
- 2004-04-19 IL IL161495A patent/IL161495A/en not_active IP Right Cessation
- 2004-04-29 NO NO20041763A patent/NO20041763L/no not_active Application Discontinuation
- 2004-12-13 US US11/011,264 patent/US8043611B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BR0213964A (pt) | 2006-05-30 |
IL161495A (en) | 2009-06-15 |
CZ2004546A3 (cs) | 2004-10-13 |
WO2003054210B1 (en) | 2004-02-26 |
US20060121579A1 (en) | 2006-06-08 |
RU2004116319A (ru) | 2005-03-27 |
KR20040066799A (ko) | 2004-07-27 |
CN1578837A (zh) | 2005-02-09 |
EP1446488A2 (en) | 2004-08-18 |
JP2005512573A (ja) | 2005-05-12 |
EP1446488A4 (en) | 2004-12-22 |
NO20041763L (no) | 2004-04-29 |
KR100984268B1 (ko) | 2010-09-30 |
CA2464268C (en) | 2012-03-20 |
AU2002365090A1 (en) | 2003-07-09 |
CN100591769C (zh) | 2010-02-24 |
WO2003054210A3 (en) | 2003-12-24 |
US8043611B2 (en) | 2011-10-25 |
WO2003054210A2 (en) | 2003-07-03 |
US20030087419A1 (en) | 2003-05-08 |
US6835568B2 (en) | 2004-12-28 |
AU2002365090B2 (en) | 2007-12-20 |
NZ533132A (en) | 2008-04-30 |
IL161495A0 (en) | 2004-09-27 |
CA2464268A1 (en) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003254139A1 (en) | H. Pylori FUCOSYLTRANSFERASES | |
ZA200603731B (en) | Plasmid system for multiple expression | |
EP1432791A4 (en) | VECTOR SYSTEMS BASED ON ALPHAVIRAL REPLICONS | |
WO2002074979A3 (en) | Expression profiles and methods of use | |
WO2002090600A3 (en) | A method for regulating immune function in primates using the foxp3 protein | |
HK1049501A1 (en) | Functional genomics using zinc finger proteins | |
WO2003093441A3 (en) | A method of regulating gene expression | |
WO2003089618A3 (en) | Transposon system and methods of use | |
MXPA04003969A (es) | Sistema de expresion de acido nucleico regulado. | |
WO2003016482A3 (en) | Methyltransferase genes and uses thereof | |
AU2003278729A1 (en) | Regulated bacterial lysis for gene vaccine vector delivery and antigen release | |
WO2002026968A3 (en) | Antisense iap nucleic acids and uses thereof | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
BR0205161A (pt) | Pó de poliamida com valor do ph ajustado para empregos cosméticos | |
ATE275956T1 (de) | Veränderung der dns methyltransferase durch kombinationstherapie | |
AP2001002104A0 (en) | Genes of the 1-desoxy-d-xylulose biosynthetic pathway. | |
EP1539794A4 (en) | BENZOATE AND AN ANTILATED PROMOTERS | |
ES2541540T3 (es) | Métodos para generar preparados exentos de helper de alto título de vectores de AAV recombinantes liberados | |
WO2004007664A3 (en) | Nucleic acid vectors | |
WO2004031210A3 (en) | Optimized multi-epitope constructs and uses thereof | |
DE69504808D1 (de) | Corticotropin freisetzende rezeptoren des faktor 2 | |
WO2003057843A8 (en) | Methods and materials for modulating trpc4 | |
WO2003100020A3 (en) | Methods and constructs for high yield expression of clostripain | |
MX2023014557A (es) | Sistemas crispr-transposon para modificacion de adn. | |
WO2003057847A8 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |